BridgeMD
New treatment option for Pelvic Organ Prolapse
Official title Accelerometer Measured Early Recovery After Prolapse Surgery
ClinicalTrials.gov ID: NCT07218016
What this study is testing
- What it's testing
- The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-reported recovery questionnaire completed daily.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99, women only
You may be able to join if
- Subject has provided written informed consent
- Ambulatory women undergoing laparoscopic, robotic, or vaginal reconstructive or obliterative surgery for apical prolapse
- POP-Q \>= Stage III
- Willing to participate in a postoperative exercise regimen
- Able to read and consent in English or Spanish
You likely can't join if
- Inability or unwillingness to adhere to the exercise intervention
- Contraindication to medium-intensity exercise
- Comorbidities preventing physical activity
- Planned abdominal approach with laparotomy
See the full eligibility criteria
- Subject has provided written informed consent
- Ambulatory women undergoing laparoscopic, robotic, or vaginal reconstructive or obliterative surgery for apical prolapse
- POP-Q \>= Stage III
- Willing to participate in a postoperative exercise regimen
- Able to read and consent in English or Spanish
- Willing and able to wear an accelerometer prior to and after surgery (including agreeing to the terms of service), use an electronic data capture software, and record daily events
- Willing and able to install and use study-related smartphone app(s)
- Anticipated hospital discharge \<= postoperative day 1
- Inability or unwillingness to adhere to the exercise intervention
- Contraindication to medium-intensity exercise
- Comorbidities preventing physical activity
- Planned abdominal approach with laparotomy
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
- Chicago, Illinois, United States
- Durham, North Carolina, United States
- Philadelphia, Pennsylvania, United States
- Providence, Rhode Island, United States
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States; Chicago, Illinois, United States; Durham, North Carolina, United States; Philadelphia, Pennsylvania, United States; Providence, Rhode Island, United States; Dallas, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.